You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Covid19 Diarrhea

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19 Trial in San Mateo, Stanford (Filtration Fan, Safe-home pamphlet, Mid-week phone call)

Enrolling by invitation
  • Covid19
  • Filtration Fan
  • +2 more
  • San Mateo, California
  • +1 more
Mar 18, 2023

Post COVID-19 Syndrome

Recruiting
  • Long COVID
  • Clinical, mental health and psychosocial profile of Post-COVID-19 syndrome
  • Diagnostic performance of echocardiographic and biological markers in Post-COVID-19 syndrome
  • Florencio Varela, Buenos Aires, Argentina
    Hospital El Cruce
Feb 17, 2023

COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)

Not yet recruiting
  • COVID-19 Respiratory Infection
  • COVID-19 Vaccine Adverse Reaction
  • DNA vaccine OC-007
  • Placebo
  • Stockholm, Region Stockholm, Sweden
    Phase I Study Unit, Karolinska University Hospital
Jan 13, 2023

COVID-19 Patients With Post-intensive Care Syndrome

Recruiting
  • Covid19
  • Post-intensive Care unit syndrome
  • Issy-les-Moulineaux, France
  • +1 more
Oct 24, 2022

Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM

Recruiting
  • Intradermal Covid-19 Vaccine
  • +3 more
  • ID BNT162b2 vaccine
  • IM BNT162b2 vaccine
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Feb 19, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)

Recruiting
  • Post Acute COVID-19 Syndrome
  • +14 more
  • stellate ganglion block with 0.5% bupivacaine
  • New York, New York
    Hudson Medical
Jan 10, 2023

Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation

Recruiting
  • Covid19_rehabilitation
  • Early rehabilitation
  • +3 more
  • Ferrara, Emilia Romagna, Italy
    Department of Neuroscience and Rehabilitation, University Hospit
Jan 11, 2023

Post-COVID-19 Syndrome Trial (intensive combined rehabilitation therapy)

Not yet recruiting
  • Post-COVID-19 Syndrome
  • intensive combined rehabilitation therapy
  • (no location specified)
Sep 8, 2022

COVID-19, Allergic Rhinitis Trial in Chengdu (no intervention)

Active, not recruiting
  • COVID-19
  • Allergic Rhinitis
  • no intervention
  • Chengdu, China
    Hospital of Chengdu University of Traditional Chinese Medicine
Mar 2, 2023

Covid19, Critical Illness, Critical Illness Polyneuromyopathy Trial in Berlin-Mitte (Robotic assisted early mobilization)

Completed
  • Covid19
  • +5 more
  • Robotic assisted early mobilization
  • Berlin-Mitte, Berlin, Germany
    Charité - Univiversitätsmedizin Berlin
Sep 9, 2022

SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)

Not yet recruiting
  • SARS-CoV-2 Infection
  • PTX-COVID19-B
  • Comirnaty®
  • (no location specified)
Sep 7, 2022

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

Covid19 Trial in Lexington (Heparin, Placebo)

Terminated
Has Results
  • Covid19
  • Lexington, Kentucky
    UK Healthcare
Oct 17, 2022

Anal Fissure Among Survivors of COVID-19 Virus Infection.

Completed
  • Anal Fissure
  • Corona Virus Infection
    • Mansoura, Egypt
      Ahmad
    Feb 22, 2023

    Re-EValuating Inhibition of Stress Erosions - COVID-19 Cohort

    Recruiting
    • COVID-19
    • GastroIntestinal Bleeding
    • Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial (NCT03374800)
    • Hamilton, Ontario, Canada
      St Joseph's Healthcare Hamilton
    Feb 6, 2023

    COVID-19 Trial (Huashi Baidu Granule, Monapiravir)

    Not yet recruiting
    • COVID-19
    • (no location specified)
    Dec 5, 2022

    COVID-19 Pneumonia, Respiratory Parameters Trial (deep breathing and coughing exercises with triflo)

    Recruiting
    • COVID-19 Pneumonia
    • Respiratory Disease
    • deep breathing and coughing exercises with triflo
    • Bartın, Turkey
      Bartın University
    Oct 8, 2022

    COVID-19 Trial (Meplazumab foe injection, Normal saline)

    Not yet recruiting
    • COVID-19
    • Meplazumab foe injection
    • Normal saline
    • (no location specified)
    Jan 16, 2023

    Post COVID19 Functional and Cognitive Assessments

    Completed
    • Covid19
    • +3 more
      • Izola, Slovenia
        SB Izola
      Sep 18, 2022

      COVID-19 on Disease Activity in Radiologically Isolated Syndrome

      Completed
      • Multiple Sclerosis
      • COVID-19
      • NO intervention
      • Nice, France
        Nice University Hospital
      Jul 29, 2022

      Anxiety and Depression Among Pregnant Women During COVID-19

      Completed
      • Covid19
      • State-trait anxiety inventory scale
      • Edinburgh Postnatal Depression Scale (EDPS)
      • Assiut, Egypt
        Assiut Faculty of Medicine
      Aug 24, 2022

      Long COVID, Long Covid19 Trial in Aurora (Narrative Intervention for Long COVID-19 (NICO))

      Active, not recruiting
      • Long COVID
      • Long Covid19
      • Narrative Intervention for Long COVID-19 (NICO)
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Oct 19, 2023

      Cardiovascular Complications in Children With COVID 19

      Not yet recruiting
      • COVID 19 Associated Coagulopathy
      • Covid 19 swap
      • (no location specified)
      Oct 22, 2023

      Covid19 Trial (Pulmonary telerehabilitation, progressive muscle relaxation training)

      Not yet recruiting
      • Covid19
      • Pulmonary telerehabilitation
      • progressive muscle relaxation training
      • (no location specified)
      Aug 2, 2022